$Teva Pharmaceutical Industries (TEVA.US)$ up 21% Premarket After Co's Bowel Disease Drug With $Sanofi (SNY.US)$ Meets Main Goals in Mid-Stage Trial
$梯瓦制药 (TEVA.US)$ 在公司治疗肠道疾病的药物上市前期上涨21% $赛诺菲安万特 (SNY.US)$ 在中期试验中达到主要目标
$Teva Pharmaceutical Industries (TEVA.US)$ up 21% Premarket After Co's Bowel Disease Drug With $Sanofi (SNY.US)$ Meets Main Goals in Mid-Stage Trial
$Teva Pharmaceutical Industries (TEVA.US)$ up 21% Premarket After Co's Bowel Disease Drug With $Sanofi (SNY.US)$ Meets Main Goals in Mid-Stage Trial
$梯瓦制药 (TEVA.US)$ 在公司治疗肠道疾病的药物上市前期上涨21% $赛诺菲安万特 (SNY.US)$ 在中期试验中达到主要目标
使用浏览器的分享功能,分享给你的好友吧